{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23823332",
  "DateCompleted": {
    "Year": "2017",
    "Month": "10",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2013",
        "Month": "06",
        "Day": "18"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e65960",
      "10.1371/journal.pone.0065960"
    ],
    "Journal": {
      "ISSN": "1932-6203",
      "JournalIssue": {
        "Volume": "8",
        "Issue": "6",
        "PubDate": {
          "Year": "2013"
        }
      },
      "Title": "PloS one",
      "ISOAbbreviation": "PLoS One"
    },
    "ArticleTitle": "Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe.",
    "Pagination": {
      "StartPage": "e65960",
      "MedlinePgn": "e65960"
    },
    "Abstract": {
      "AbstractText": [
        "Controlled human malaria infection (CHMI) studies have become a routine tool to evaluate efficacy of candidate anti-malarial drugs and vaccines. To date, CHMI trials have mostly been conducted using the bite of infected mosquitoes, restricting the number of trial sites that can perform CHMI studies. Aseptic, cryopreserved P. falciparum sporozoites (PfSPZ Challenge) provide a potentially more accurate, reproducible and practical alternative, allowing a known number of sporozoites to be administered simply by injection.",
        "We sought to assess the infectivity of PfSPZ Challenge administered in different dosing regimens to malaria-naive healthy adults (n\u200a=\u200a18). Six participants received 2,500 sporozoites intradermally (ID), six received 2,500 sporozoites intramuscularly (IM) and six received 25,000 sporozoites IM.",
        "Five out of six participants receiving 2,500 sporozoites ID, 3/6 participants receiving 2,500 sporozoites IM and 6/6 participants receiving 25,000 sporozoites IM were successfully infected. The median time to diagnosis was 13.2, 17.8 and 12.7 days for 2,500 sporozoites ID, 2,500 sporozoites IM and 25,000 sporozoites IM respectively (Kaplan Meier method; p\u200a=\u200a0.024 log rank test).",
        "2,500 sporozoites ID and 25,000 sporozoites IM have similar infectivities. Given the dose response in infectivity seen with IM administration, further work should evaluate increasing doses of PfSPZ Challenge IM to identify a dosing regimen that reliably infects 100% of participants.",
        "ClinicalTrials.gov NCT01465048."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United Kingdom ; The Jenner Institute Laboratories, University of Oxford, Oxford, United Kingdom."
          }
        ],
        "LastName": "Sheehy",
        "ForeName": "Susanne H",
        "Initials": "SH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Spencer",
        "ForeName": "Alexandra J",
        "Initials": "AJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Douglas",
        "ForeName": "Alexander D",
        "Initials": "AD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sim",
        "ForeName": "B Kim Lee",
        "Initials": "BK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Longley",
        "ForeName": "Rhea J",
        "Initials": "RJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Edwards",
        "ForeName": "Nick J",
        "Initials": "NJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Poulton",
        "ForeName": "Ian D",
        "Initials": "ID"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kimani",
        "ForeName": "Domtila",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Williams",
        "ForeName": "Andrew R",
        "Initials": "AR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Anagnostou",
        "ForeName": "Nicholas A",
        "Initials": "NA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Roberts",
        "ForeName": "Rachel",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kerridge",
        "ForeName": "Simon",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Voysey",
        "ForeName": "Merryn",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "James",
        "ForeName": "Eric R",
        "Initials": "ER"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Billingsley",
        "ForeName": "Peter F",
        "Initials": "PF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gunasekera",
        "ForeName": "Anusha",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lawrie",
        "ForeName": "Alison M",
        "Initials": "AM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hoffman",
        "ForeName": "Stephen L",
        "Initials": "SL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hill",
        "ForeName": "Adrian V S",
        "Initials": "AV"
      }
    ],
    "DataBankList": [
      {
        "DataBankName": "ClinicalTrials.gov",
        "AccessionNumberList": [
          "NCT01465048"
        ]
      }
    ],
    "GrantList": [
      {
        "GrantID": "089455/2/09/Z",
        "Acronym": "WT_",
        "Agency": "Wellcome Trust",
        "Country": "United Kingdom"
      },
      {
        "GrantID": "097940/Z/11/Z",
        "Acronym": "WT_",
        "Agency": "Wellcome Trust",
        "Country": "United Kingdom"
      },
      {
        "GrantID": "R44 AI058375",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "A91301",
        "Acronym": "DH_",
        "Agency": "Department of Health",
        "Country": "United Kingdom"
      },
      {
        "GrantID": "090532",
        "Agency": "Wellcome Trust",
        "Country": "United Kingdom"
      },
      {
        "GrantID": "084113/Z/07/Z",
        "Acronym": "WT_",
        "Agency": "Wellcome Trust",
        "Country": "United Kingdom"
      },
      {
        "GrantID": "45488/Z/05",
        "Acronym": "WT_",
        "Agency": "Wellcome Trust",
        "Country": "United Kingdom"
      },
      {
        "Agency": "Wellcome Trust",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Research Support, N.I.H., Extramural"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS One",
    "NlmUniqueID": "101285081",
    "ISSNLinking": "1932-6203"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Cryopreservation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Enzyme-Linked Immunosorbent Assay"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "parasitology",
        "prevention & control"
      ],
      "DescriptorName": "Malaria, Falciparum"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Needles"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pilot Projects"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Syringes"
    }
  ],
  "CoiStatement": "<b>Competing Interests: </b>BKLS, ERJ, PFB, AG, and SLH are employees of Sanaria Inc., which manufactures PfSPZ Challenge. Sanaria also manufactures other products in development based on aseptic, purified, cryopreserved PfSPZ, including PfSPZ Vaccine and PfSPZ-CVac. Sanaria sells parasites and mosquitoes to the research community, but none of its major products in development have been commercialized. BKLS and SLH are inventors on patents relevant to PfSPZ Challenge. None of the authors have had any consultancies relevant to this paper. This conflict of interest does not alter these authors\u2019 adherence to all PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors."
}